Company intelligence / Profile preview

Tomophase

Burlington, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Tomophase is a medical device company that specialized in the development of Optical Coherence Tomography (OCT) technology for pulmonary applications. The company's primary product, the Tomophase OCT Imaging System, was designed to provide high-resolution, real-time cross-sectional images of the airway wall and sub-surface tissue during bronchoscopy. This "optical biopsy" capability aimed to improve the diagnosis and management of respiratory conditions such as lung cancer, COPD, and asthma. Although the technology received FDA clearance, the company is currently considered inactive.

Therapeutic areas: OncologyPulmonology
Modalities: Device
Industry: Medical Imaging

Partnerships

Massachusetts General Hospital

Beyond the preview

Go deeper on Tomophase.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tomophase.

Explore the full profile